Results 151 to 160 of about 883,208 (316)

Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis

open access: yesCardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Background Drug‐coated balloons (DCBs) present a viable option distinct from drug‐eluting stents (DESs) in addressing coronary artery disease (CAD), particularly when it comes to in‐stent restenosis (ISR) scenarios. The utilization of DCBs marks a significant deviation from traditional DES applications.
Yue Yu   +6 more
wiley   +1 more source

SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis

open access: yesFrontiers in Cardiovascular Medicine
Coronary heart disease is a narrowing or obstruction of the vascular cavity caused by atherosclerosis of the coronary arteries, which leads to myocardial ischemia and hypoxia. At present, percutaneous coronary intervention (PCI) is an effective treatment
Qing Zhang   +4 more
doaj   +1 more source

Syndromic Congenital Heart Disease Diagnosed in Adulthood: A Reminder of the Phenotypic Variability of Alagille Syndrome

open access: yesCase Reports in Cardiology, Volume 2026, Issue 1, 2026.
Alagille syndrome is a rare multisystemic genetic condition most commonly associated with neonatal liver disease. Variable expressivity is a defining feature of Alagille syndrome, resulting in a broad spectrum of phenotypic variation among individuals who meet the diagnostic criteria. We present an atypical case of cardiac‐predominant Alagille syndrome
Matthew K. Campbell   +4 more
wiley   +1 more source

Clinical and angiography factors influencing long-term coronary stenting results

open access: yesКардиоваскулярная терапия и профилактика, 2005
Aim. To study long-term results of coronary artery (CA) stenting, according to baseline clinical and coronaroangiography (CAG) data. Material and methods. The study included 66 males who underwent coronary stent implantation.
S. O. Sokolova   +5 more
doaj  

Is a Prior History of PCI a Predictor of MACE Within 1 Year of CABG, a Propensity‐Matched Analysis Using Optimal Matching

open access: yesJournal of Cardiac Surgery, Volume 2026, Issue 1, 2026.
Background Percutaneous coronary intervention (PCI) is an effective option for myocardial revascularization, even for high‐risk patients. As a result, more patients who undergo coronary artery bypass grafting (CABG) have previously had PCI. This study aims to assess the impact of prior PCI on the occurrence of major adverse cardiac events (MACEs ...
Hani N. Mufti   +8 more
wiley   +1 more source

Antioxidant system gene polymorphism and restenosis risk after coronary stenting

open access: yesКардиоваскулярная терапия и профилактика, 2008
Aim. To study the links between four polymorphisms of three antioxidant enzymes (catalase, paraoxonase, endothelial NO synthase) and restenosis risk after coronary artery stenting (CAS).Material and methods. The study included male patients with coronary
Yu. A. Shuvalova   +6 more
doaj  

Effects of balloon injury on neointimal hyperplasia in steptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. [PDF]

open access: yes, 2001
BACKGROUND: The mechanisms of increased neointimal hyperplasia after coronary interventions in diabetic patients are still unknown. METHODS AND RESULTS: Glucose and insulin effects on in vitro vascular smooth muscle cell (VSMC) proliferation and ...
Carriero M.V.   +13 more
core  

The Role of Extracellular Matrix within the Neointima in A Porcine Coronary Stent Restenosis Model [PDF]

open access: bronze, 2003
Ok Young Park   +12 more
openalex   +1 more source

Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention

open access: yesРациональная фармакотерапия в кардиологии
Aim. To study the relationship between plasma levels of lipoprotein(a) (Lp(a)), vascular endothelial growth factor (VEGF), transforming growth factor β (TGF-β), and the occurrence of stent restenosis after percutaneous coronary intervention (PCI) in ...
M. А. Meshkova   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy